{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:16:14Z","timestamp":1794806174676,"version":"4.9.1"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:sec id=\"ab-yoi260032-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Revealing neurobiological markers of antipsychotic nonresponse in psychosis may aid outcome prediction and inform novel treatment targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi260032-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine differences in neurometabolites in antipsychotic nonresponsive compared to antipsychotic-responsive psychosis using individual participant data and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi260032-6\">\n                    <jats:title>Data Sources<\/jats:title>\n                    <jats:p>Web of Science was searched for studies published between January 1, 1980, and November 1, 2025. Authors of 21 eligible studies identified before August 2024 were invited to contribute individual participant data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi260032-7\">\n                    <jats:title>Study Selection<\/jats:title>\n                    <jats:p>Eighteen studies examining neurometabolites by treatment response in psychosis contributed individual participant data for the mega-analysis. These studies plus a further 5 studies were included in the meta-analyses of standardized mean differences and variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi260032-8\">\n                    <jats:title>Data Extraction and Synthesis<\/jats:title>\n                    <jats:p>Individual participant data were analyzed using linear mixed models with study as a random effect. Subgroup analyses examined prospective designs and treatment-resistant samples. Published group means and standard deviations were extracted for meta-analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi260032-9\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      Group differences in glutamate, glutamate plus glutamine, choline, myo-inositol,\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -acetylaspartate, \u03b3-aminobutyric acid, and glutathione in the medial frontal cortex, dorsolateral prefrontal cortex, thalamus, and basal ganglia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi260032-10\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mega-analysis included 1189 participants from 18 studies; of these, 476 were treatment nonresponders (mean [SD] age, 33.0 [12.5] years; 340 male), 427 were treatment responders (mean [SD] age, 30.3 [11.5] years; 299 male), and 286 were healthy control individuals (mean [SD] age, 31.0 [12.5] years; 170 male). Compared with the antipsychotic response group, nonresponders showed elevations in medial frontal glutamate (Glass \u0394\u2009=\u20090.21;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.02), glutamate plus glutamine (Glass \u0394\u2009=\u20090.29;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.002), choline (Glass \u0394\u2009=\u20090.22;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.03), and myo-inositol (Glass \u0394\u2009=\u20090.35;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.001); similar elevations were observed relative to control individuals. Elevated medial frontal glutamate plus glutamine in antipsychotic nonresponders compared with responders was also observed prospectively in first-episode psychosis (Glass \u0394\u2009=\u20090.41;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.002), whereas myo-inositol elevations were greatest in individuals meeting criteria for treatment-resistance (Glass \u0394\u2009=\u20090.64;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.001). The meta-analysis of 23 studies (1844 participants) also showed elevated medial frontal choline and myo-inositol in antipsychotic nonresponse compared with response.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi260032-11\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>These findings provide evidence of an association between antipsychotic nonresponse in psychosis with elevations in medial frontal glutamate, choline, and myo-inositol. The presence of elevations in these markers supports the continued investigation of glutamate-acting and inflammatory pathway\u2013associated interventions for psychosis and schizophrenia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2026.1674","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:33:02Z","timestamp":1782315182000},"page":"939","source":"Crossref","is-referenced-by-count":4,"title":["Neurometabolites and Antipsychotic Response in Psychosis"],"prefix":"10.1001","volume":"83","author":[{"given":"Bridget","family":"King","sequence":"first","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Borup","family":"Bojesen","sequence":"additional","affiliation":[{"name":"Center for Neuropsychiatric Schizophrenia Research (CNSR) & Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Center Glostrup, Copenhagen University Hospital \u2013 Mental Health Services CPH, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Crisp","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"de Bartolomeis","sequence":"additional","affiliation":[{"name":"Clinical Section on Psychiatry and Psychology, Unit of Treatment Resistant Psychosis, Laboratory of Molecular and Translational Psychiatry, Department of Neuroscience, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieuwe","family":"de Haan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"de la Fuente-Sandoval","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Psychiatry, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Dempster","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Drake","sequence":"additional","affiliation":[{"name":"Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, Manchester, United Kingdom"},{"name":"Greater Manchester Mental Health National Health Service (NHS) Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Dazzan","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley National Health Service (NHS) Foundation Trust and King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn H.","family":"Ebdrup","sequence":"additional","affiliation":[{"name":"Center for Neuropsychiatric Schizophrenia Research (CNSR) & Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Center Glostrup, Copenhagen University Hospital \u2013 Mental Health Services CPH, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejia","family":"Fan","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, China"},{"name":"Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte Yding","family":"Glenth\u00f8j","sequence":"additional","affiliation":[{"name":"Center for Neuropsychiatric Schizophrenia Research (CNSR) & Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Center Glostrup, Copenhagen University Hospital \u2013 Mental Health Services CPH, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"},{"name":"Department of Psychiatry and Behavioral Health, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Howes","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chung","family":"Huang","sequence":"additional","affiliation":[{"name":"Psychiatry Department, Chia Yi Branch, Taichung Veterans General Hospital, Chia Yi, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Kahn","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"MacCabe","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Matrone","sequence":"additional","affiliation":[{"name":"NESMOS (Neurosciences, Mental Health, and Sensory Organs) Department, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Merritt","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, UCL, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"McIlwain","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Lawrie","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Palaniyappan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Douglas Research Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Reyes-Madrigal","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Psychiatry, Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Russell","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Otago, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sawa","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry, Neuroscience, Biomedical Engineering, Pharmacology, and Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Department of Mental Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhi","family":"Shergill","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"Kent and Medway Medical School, Canterbury, Kent, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krish D.","family":"Singh","sequence":"additional","affiliation":[{"name":"Cardiff University Brain Research Imaging Centre, School of Psychology, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris E.","family":"Sommer","sequence":"additional","affiliation":[{"name":"Center for Clinical Neuroscience and Cognition, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Stone","sequence":"additional","affiliation":[{"name":"Brighton and Sussex Medical School (BSMS), University of Sussex, Brighton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Tsugawa","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Ueno","sequence":"additional","affiliation":[{"name":"Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"van der Pluijm","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsmarieke","family":"van de Giessen","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T. R.","family":"Walters","sequence":"additional","affiliation":[{"name":"Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Kuang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"},{"name":"Institute of Behavioral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan"},{"name":"Department of Psychiatry, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Kempton","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Egerton","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"yoi260032r1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group consensus guidelines on diagnosis and terminology.","volume":"174","author":"Howes","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"1","key":"yoi260032r2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia\u2013the role of clozapine.","volume":"14","author":"Meltzer","year":"1997","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"yoi260032r3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41386-020-00866-7","article-title":"A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach.","volume":"46","author":"Veronese","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yoi260032r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","article-title":"A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.","volume":"39","author":"Rae","year":"2014","journal-title":"Neurochem Res"},{"issue":"1","key":"yoi260032r5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41380-021-01297-6","article-title":"Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.","volume":"27","author":"Nakahara","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"6","key":"yoi260032r6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/jamapsychiatry.2021.0380","article-title":"Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of individual participant-level data.","volume":"78","author":"Merritt","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"yoi260032r7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bpsc.2023.10.008","article-title":"Greater choline-containing compounds and myo-inositol in treatment-resistant vs responsive schizophrenia: a 1H magnetic resonance spectroscopy meta-analysis.","volume":"9","author":"Smucny","year":"2024","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"13","key":"yoi260032r8","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1017\/S0033291719002277","article-title":"Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-na\u00efve patients with psychosis.","volume":"50","author":"Bojesen","year":"2020","journal-title":"Psychol Med"},{"issue":"11","key":"yoi260032r9","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1038\/s41380-018-0082-9","article-title":"Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE).","volume":"23","author":"Egerton","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"3","key":"yoi260032r10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41386-022-01508-w","article-title":"Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration.","volume":"48","author":"Egerton","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"yoi260032r11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41386-023-01741-x","article-title":"Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex.","volume":"49","author":"Fan","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"yoi260032r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110473","article-title":"Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients.","volume":"113","author":"Reyes-Madrigal","year":"2022","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"yoi260032r13","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/s41380-021-01331-7","article-title":"A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance.","volume":"27","author":"Yang","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"8","key":"yoi260032r14","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41380-020-0704-x","article-title":"Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate.","volume":"25","author":"Dempster","year":"2020","journal-title":"Mol Psychiatry"},{"key":"yoi260032r15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.553269","article-title":"Anterior cingulate cortex glutamate levels are related to response to initial antipsychotic treatment in drug-naive first-episode schizophrenia patients.","volume":"11","author":"Li","year":"2020","journal-title":"Front Psychiatry"},{"key":"yoi260032r16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.schres.2024.01.025","article-title":"Glutamate and GABA levels in the anterior cingulate cortex in treatment resistant first episode psychosis patients.","volume":"264","author":"van der Pluijm","year":"2024","journal-title":"Schizophr Res"},{"issue":"5","key":"yoi260032r17","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1038\/s41380-023-01991-7","article-title":"Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.","volume":"28","author":"Merritt","year":"2023","journal-title":"Mol Psychiatry"},{"key":"yoi260032r18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.796466","article-title":"Schizophrenia increases variability of the central antioxidant system: a meta-analysis of variance from MRS studies of glutathione.","volume":"12","author":"Palaniyappan","year":"2021","journal-title":"Front Psychiatry"},{"issue":"1","key":"yoi260032r19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews.","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"1","key":"yoi260032r20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4.","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"issue":"2","key":"yoi260032r22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.32614\/RJ-2017-066","article-title":"glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling.","volume":"9","author":"Brooks","year":"2017","journal-title":"R J"},{"issue":"3","key":"yoi260032r23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package.","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"11","key":"yoi260032r24","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/jamapsychiatry.2017.2663","article-title":"Heterogeneity and homogeneity of regional brain structure in schizophrenia: a meta-analysis.","volume":"74","author":"Brugger","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"yoi260032r25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-3-642-28711-4","article-title":"MR spectroscopic studies of the brain in psychiatric disorders.","volume":"11","author":"Maddock","year":"2012","journal-title":"Curr Top Behav Neurosci"},{"issue":"11","key":"yoi260032r26","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/j.1528-1167.2012.03685.x","article-title":"In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity.","volume":"53","author":"Filibian","year":"2012","journal-title":"Epilepsia"},{"issue":"2","key":"yoi260032r27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.pnpbp.2006.09.013","article-title":"Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol.","volume":"31","author":"Rothermundt","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"yoi260032r28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/schbul\/sbv118","article-title":"Elevated myo-inositol, choline and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: a proton magnetic resonance spectroscopy study with implications for glial dysfunction.","volume":"42","author":"Plitman","year":"2016","journal-title":"Schizophr Bull"},{"key":"yoi260032r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2023.103461","article-title":"Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.","volume":"39","author":"Yang","year":"2023","journal-title":"Neuroimage Clin"},{"key":"yoi260032r21","unstructured":"Lenth? RV. emmeans: estimated marginal means, aka least-squares means. R package. Published 2023. Accessed December 2025. https:\/\/CRAN.R-project.org\/package=emmeans"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2850582\/jamapsychiatry_king_2026_oi_260032_1788289929.39119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:00:36Z","timestamp":1788361236000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2850582"}},"subtitle":["A Mega-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2026.1674","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}